RecruitingPhase 4NCT07228052

Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department

Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department: A Randomized Control Trial


Sponsor

Montefiore Medical Center

Enrollment

182 participants

Start Date

Jul 23, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare the efficacy of a one-time IM dose of dexamethasone versus a 5-day course of prednisone in adult ED patients presenting with asthma exacerbations. This is a randomized, controlled, double-blind, non-inferiority trial conducted at two urban EDs within the Montefiore Health System.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dexamethasone 16mg IM and a drug called Prednisone 60mg PO for people with asthma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexamethasone 16mg IM

Dexamethasone 16mg Intramuscular Administration Once

DRUGPrednisone 60mg PO

Prednisone 60mg PO for 5 Days


Locations(1)

Montefiore Medical Center

The Bronx, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07228052


Related Trials